EBON vs NCEL
Comparison between Ebang International Holdings Inc - Class A (EBON, Company) and NLS Pharmaceutics Ltd (NCEL, Company).
EBON is from the Technology sector, while NCEL is from the Healthcare sector.
5-Year PerformanceEBON has outperformed NCEL, delivering a return of -52.9% compared to -69.4%
EBON vs NCEL - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
EBON vs NCEL - Historical Returns
Returns include dividend reinvestment.
EBON vs NCEL - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | EBON | NCEL |
|---|---|---|
| 2026 | -20.63% | +58.37% |
| 2025 | -51.89% | -91.28% |
| 2024 | -58.22% | -91.03% |
| 2023 | +425.77% | -57.86% |
| 2022 | -90.85% | +8.40% |
| 2021 | -85.57% | -61.59% |
| 2020 | +21.40% | N/A |
EBON vs NCEL Drawdown Comparison
The maximum drawdown for EBON was -99.51%, occurring on Mar 31, 2026. This drawdown has not yet recovered.
The maximum drawdown for NCEL was -99.92%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The current EBON drawdown is -99.28%. The current NCEL drawdown is -99.86%.
| Rank | EBON | NCEL |
|---|---|---|
| #1 | -99.51% Mar 17, 2021 - Mar 31, 2026 | -99.92% Mar 12, 2021 - Mar 30, 2026 |
| #2 | -62.70% Sep 17, 2020 - Feb 18, 2021 | -35.41% Feb 11, 2021 - Mar 12, 2021 |
| #3 | -50.22% Feb 18, 2021 - Mar 17, 2021 | -9.34% Jan 29, 2021 - Feb 3, 2021 |
| #4 | -23.64% Jul 15, 2020 - Aug 14, 2020 | -7.69% Feb 4, 2021 - Feb 11, 2021 |
| #5 | -20.60% Jun 26, 2020 - Jul 15, 2020 | N/A |
| #6 | -14.14% Aug 14, 2020 - Sep 3, 2020 | N/A |
| #7 | -4.97% Sep 4, 2020 - Sep 10, 2020 | N/A |
| #8 | -1.41% Sep 10, 2020 - Sep 14, 2020 | N/A |
| #9 | -0.63% Sep 14, 2020 - Sep 16, 2020 | N/A |
Correlation
Correlation between EBON and NCEL is 0.84 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks